A review of neuraminidase inhibitor susceptibility in influenza strains.
about
Multi-Omics Studies towards Novel Modulators of Influenza A Virus-Host InteractionInfluenza Neuraminidase Inhibitors: Synthetic Approaches, Derivatives and Biological ActivityTwo Escape Mechanisms of Influenza A Virus to a Broadly Neutralizing Stalk-Binding AntibodyTravellers and influenza: risks and prevention.Investigational hemagglutinin-targeted influenza virus inhibitors.Structure prediction and analysis of neuraminidase sequence variants.Reduction of Neuraminidase Activity Exacerbates Disease in 2009 Pandemic Influenza Virus-Infected Mice.Anti-infective Activity of 2-Cyano-3-Acrylamide Inhibitors with Improved Drug-Like Properties against Two Intracellular Pathogens.Investigating the role of MRGPRC11 and capsaicin-sensitive afferent nerves in the anti-influenza effects exerted by SLIGRL-amide in murine airways.Learning from structure-based drug design and new antivirals targeting the ribonucleoprotein complex for the treatment of influenza.Antiviral treatment of influenza in South Korea.Rates and effectiveness of antiviral use among hospitalized influenza patients.Quercetin as an Antiviral Agent Inhibits Influenza A Virus (IAV) Entry.Phosphoproteomics to Characterize Host Response During Influenza A Virus Infection of Human MacrophagesInfluenza Virus Infection, Interferon Response, Viral Counter-Response, and Apoptosis.Discovery of Influenza A virus neuraminidase inhibitors using support vector machine and Naïve Bayesian models.High throughput discovery of influenza virus neutralizing antibodies from phage-displayed synthetic antibody libraries.Pharmacodynamics, Pharmacokinetics, and Antiviral Activity of BAY 81-8781, a Novel NF-κB Inhibiting Anti-influenza Drug.Whole genome sequencing identifies influenza A H3N2 transmission and offers superior resolution to classical typing methods.Molecular genetic characteristics of influenza A virus clinically isolated during 2011-2016 influenza seasons in Korea.Evolution of Therapeutic Antibodies, Influenza Virus Biology, Influenza, and Influenza Immunotherapy.Susceptibility of influenza viruses to hypothiocyanite and hypoiodite produced by lactoperoxidase in a cell-free system
P2860
Q28073474-AC26E7A4-48FD-466C-933B-401F5BECED11Q28079041-9E2B4137-A536-4A17-A6C8-AA7992E59798Q28552195-53E4B37E-BA9D-43B0-A98A-4D445D13A853Q30239068-626AF1C6-C4A6-45F2-ADF9-176A694A5326Q30240175-1CCDAB3E-E7E1-4AC6-AC9B-CC2F74618F5FQ30384706-E3934F5B-28E5-428C-A566-F52782B059D2Q30392198-45833C07-12BC-4776-AEB7-3150EC2C087BQ36006797-1FF9CD9E-2C18-41FC-BE0B-C1DEE0561070Q36929568-A2816513-E622-4D0B-9D5C-3C90D11F1EA3Q38384758-70B0ADA9-438B-4DCC-A99E-1B47103A99B9Q38401883-CA8FB37D-A719-41AC-B385-296988D0F802Q38476530-0C0AD4DD-C082-48C9-BADA-ABCCE2C22201Q38927096-7558A9D3-CB4D-4D92-B7E8-19670D33D5F6Q39530544-0565C2B8-05D7-4AD1-83C2-51C706B7318CQ40084055-6BB6D9FF-3A18-4C12-8416-AAED93975646Q41033255-A7FAAED2-1551-4440-8E5F-FCB9606A68A7Q45325444-2B9333E1-0ECA-40B7-87AE-237DEA0E1C1BQ45859986-7FA05A2A-EDB3-47BE-ADAE-A9162CBABD56Q47595282-27662ED6-AA14-4499-8D78-7321ECED1382Q53705887-5305A0CF-0B01-4B5A-95AF-F0FBBAFF996DQ55554478-8322A8BE-17DB-4C65-AF9C-CA4CF39684C1Q56987224-14C13F3D-5C7F-474A-8D0A-730398ED6472
P2860
A review of neuraminidase inhibitor susceptibility in influenza strains.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
A review of neuraminidase inhibitor susceptibility in influenza strains.
@en
type
label
A review of neuraminidase inhibitor susceptibility in influenza strains.
@en
prefLabel
A review of neuraminidase inhibitor susceptibility in influenza strains.
@en
P2093
P2860
P1476
A review of neuraminidase inhibitor susceptibility in influenza strains.
@en
P2093
Athanassios Tsakris
Nick Spanakis
Vassiliki Gennimata
Vassiliki Pitiriga
P2860
P304
P356
10.1586/14787210.2014.966083
P577
2014-11-01T00:00:00Z